Company
Headquarters: Jakarta Timur, Indonesia
Employees: 4,958
Rp6.312 Trillion
IDR as of July 1, 2024
US$385.5 Million
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $75.67 B |
Cencora, Inc. | $43.82 B |
Cardinal Health, Inc. | $23.31 B |
Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
Sinopharm Group Co. Ltd | $8.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia. The company operates through three segments: Pharmaceutical, Consumer Products, and Others. It also trades in medical and laboratory equipment and supplies; operates health care clinics; and offers dental and other equipment, as well as calibration services. In addition, the company engages in the trading of raw materials for pharmaceutical products; consumable products for hemodialysis therapy; and food and beverages. Further, it offers warehousing services, including chiller, cool, and ambient rooms, as well as container chiller as facilities. The company was formerly known as PT Arya Gupta Cempaka and changed its name to PT Enseval Putera Megatrading Tbk. in August 1993. The company was incorporated in 1973 and is headquartered in East Jakarta, Indonesia. PT Enseval Putera Megatrading Tbk. is a subsidiary of PT Kalbe Farma Tbk.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
PT Enseval Putera Megatrading Tbk has the following listings and related stock indices.
Stock: IDX: EPMT wb_incandescent